Department of NanoEngineering and Moores Cancer Center , University of California San Diego , La Jolla , California 92093 , United States.
Bioconjug Chem. 2018 Mar 21;29(3):604-612. doi: 10.1021/acs.bioconjchem.7b00692. Epub 2017 Dec 27.
As nanoparticles exhibit unique properties attractive for vaccine development, they have been progressively implemented as antigen delivery platforms and immune potentiators. Recently, cell membrane-coated nanoparticles have provided a novel approach for intercepting and neutralizing bacterial toxins by leveraging their natural affinity to cellular membranes. Such toxin-nanoparticle assemblies, termed nanotoxoids, allow rapid loading of different types of toxins and have been investigated for their ability to effectively confer protection against bacterial infection. This topical review will cover the current progress in antibacterial vaccine nanoformulations and highlight the nanotoxoid platform as a novel class of nanoparticulate vaccine. We aim to provide insights into the potential of nanotoxoids as a platform that is facile to implement and can be broadly applied to help address the rising threat of super pathogens.
由于纳米颗粒表现出独特的性质,非常适合用于疫苗开发,因此它们逐渐被用作抗原传递平台和免疫增强剂。最近,细胞膜包覆的纳米颗粒提供了一种新的方法来拦截和中和细菌毒素,利用它们与细胞膜的天然亲和力。这种毒素-纳米颗粒组装体,称为纳米毒素,允许快速加载不同类型的毒素,并已被研究用于有效提供针对细菌感染的保护。本专题综述将涵盖抗菌疫苗纳米制剂的最新进展,并强调纳米毒素平台作为一类新型的纳米颗粒疫苗。我们旨在提供对纳米毒素作为一种易于实施且可广泛应用的平台的潜力的深入了解,以帮助应对超级病原体日益增长的威胁。